Claims for Patent: 5,310,878
✉ Email this page to a colleague
Summary for Patent: 5,310,878
Title: | Biosynthetic cerebrospinal fluid control and method of use |
Abstract: | A biosynthetic cerebrospinal fluid control and method of use. Additionally, this invention relates to the isolation and purification of stable liquid human prealbumin, a component in the biosynthetic cerebrospinal fluid control. |
Inventor(s): | Herring; Kathryn D. (Miami, FL) |
Assignee: | Baxter Diagnostics Inc. (Deerfield, IL) |
Application Number: | 07/965,456 |
Patent Claims: | 1. A method for purifying prealbumin comprising:
(a) diluting human serum with a first buffer; (b) extracting globulins, ceroplasm and albumin from said human serum of Step (a) after dilution using ion exchange chromatography resulting in at least one fraction containing prealbumin; (c) isolating said prealbumin containing fractions eluted from Step (b) by immunodiffusion; (d) pooling said prealbumin containing fractions of Step (c) and concentrating and buffer exchanging said resulting prealbumin containing pooled fraction with a second buffer; (e) removing albumin from said prealbumin containing pooled fraction of Step (d) affinity chromatography; (f) isolating the prealbumin containing fractions eluted from Step (e) by immunodiffusion; (g) pooling said prealbumin containing fractions of Step (e) and concentrating and buffer exchanging said resulting prealbumin containing pooled fraction of Step (f) with a third buffer; (h) removing globulins from said prealbumin containing pooled fraction of Step (g) by ion exchange chromatography; (i) pooling, concentrating and buffer exchanging said prealbumin containing fraction of Step (h) with a fourth buffer; (j) purifying said prealbumin containing fraction of Step (i) by gel filtration to remove any residual proteins; (k) isolating said purified prealbumin fractions from Step (j); and (l) pooling, concentrating and sterile filtering said purified prealbumin fractions of Step (k); wherein the method yield is greater than about 60% prealbumin. 2. The method of claim 1 wherein the affinity chromatography media is 1-amino-4-((4-((4-chloro-6-((3(or 4)-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-3-sulfophenyl)amino)-9,10- dihydro-9,10-dioxo-2-Anthracenesulfonic acid dye. 3. The method of claim 1 wherein said purified prealbumin fractions of Step (k) are isolated by electrophoresis and immunodiffusion. 4. The method of claim 1 wherein the ion exchange media is selected from the class consisting of diethylaminoethyl crosslinked cellulose ion exchange chromatography media or diethylaminoethyl crosslinked agarose (Pharmacia) ion exchange chromatography media. 5. The method of claim 1 wherein the gel filtration media is a mixture of polyacrylamide and agarose. |
Details for Patent 5,310,878
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2040-01-28 |
Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2040-01-28 |
Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2040-01-28 |
Grifols Biologicals Llc | ALBUTEIN | albumin (human) | Injection | 102478 | 08/15/1978 | ⤷ Try a Trial | 2040-01-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.